Springworks Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPRINGWORKS, and when can generic versions of SPRINGWORKS drugs launch?
SPRINGWORKS has one approved drug.
There are sixteen US patents protecting SPRINGWORKS drugs.
There are sixty-four patent family members on SPRINGWORKS drugs in forty-four countries.
Drugs and US Patents for Springworks
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-001 | Nov 27, 2023 | RX | Yes | Yes | 7,342,118 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-001 | Nov 27, 2023 | RX | Yes | Yes | 11,872,211 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-001 | Nov 27, 2023 | RX | Yes | Yes | 7,795,447 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-001 | Nov 27, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Springworks | OGSIVEO | nirogacestat hydrobromide | TABLET;ORAL | 217677-001 | Nov 27, 2023 | RX | Yes | Yes | 11,884,634 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Springworks Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
El Salvador | 2006002055 | ⤷ Try a Trial |
Dominican Republic | P2005000040 | ⤷ Try a Trial |
Peru | 20221252 | ⤷ Try a Trial |
Netherlands | 1028598 | ⤷ Try a Trial |
Croatia | P20080375 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.